Qiming Venture Leads $8M Series A Round In Chinese CRO Start-Up dMed

This Data Is Locked!

This area is available only to Subscribers.

Qiming Venture Capital has led a US$8 million series A funding round in dMed Co., Ltd., a Chinese clinical contract research organization (CRO), with participation... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?